Delivery Order SPE2DB22D2108-SPE2DB25FU5FA
- Not listed
- The Defense Logistics Agency awarded a $1,349.32 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Potassium Chloride ER 10 MEQ tablets in quantities of 1,000 units, with completion scheduled for July 28, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,015.55 delivery order to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 20 MEQ tablets (100-count packaging) under a firm fixed price contract. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.40 firm fixed-price delivery order is for the supply of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- The Defense Logistics Agency awarded a $1,146.36 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Potassium Chloride 10 milliequivalents per 100 milliliters solution in 100-milliliter units. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,578.25, is for the delivery of potassium chloride extended-release 8 milliequivalent tablets in 500-count packages. The contract has a firm fixed-price pricing type and an ultimate completion date of October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of a medication, Potassium Chloride Extended Release 20 MEQ Tablet, and has a ceiling value of $8,528.61. The contract does not have a set-aside designation, indicating it was open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $15,878 delivery order contract to Amerisourcebergen Drug Corporation for potassium chloride extended release tablets. Under the firm fixed price contract, Amerisourcebergen will provide 500 tablets to support the Department of Defense's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 31st to September 1st, 2023. No subcontractors or set aside designations were...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,104.43 firm fixed-price delivery order is for the supply of 4560970833 potassium chloride extended-release 8 milliequivalent (MEQ) tablets in 500-count bottles. The contract has a performance period ending on May 18, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,778 potassium chloride extended-release tablets in packages of 500. The contract has a ceiling value of $1,349.95 and a completion date of April 17, 2024. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen,...
- This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,273.14 firm-fixed-price delivery order is for the supply of 4,564,602,240 units of Potassium Chloride 10% (20 MEQ/15 ML) in 15 ML cups. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5FADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 milliequivalent tablets in quantities of 500 units. This firm fixed price delivery order, valued at $6,588.65, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement supporting global pharmaceutical procurement for military healthcare systems through December 2026. The order is non-competitive and scheduled for completion by July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills extensive pharmaceutical and medical supply needs across the Department of Defense and federal healthcare systems. The Potassium Chloride supply under this delivery order supports military medical operations and veteran healthcare programs, consistent with the company's portfolio of generic and brand-name medications, vaccines, and medical devices delivered through competitively awarded contracts with DLA. As a key participant in the Pharmaceutical Prime Vendor Global Program, AmerisourceBergen continues to serve as a strategic supplier for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities requiring reliable pharmaceutical sourcing and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/24/25 |